Hans Hammers
Dr. Hammers has initiated a project to determine the mechanisms of resistance of advanced prostate cancer to angiogenesis inhibitors, like Avastin, that block the development of new blood vessels that...Read More
David S. Finley
Obesity increases the risk of developing prostate cancer and most major cancers. New data suggests that adipose tissue (body fat), now considered an “organ,” is capable of secreting numerous molecules...Read More
Robert Den
Radiation therapy in combination with medicines that block testosterone (hormonal therapy) is a common treatment for locally advanced prostate cancer. However, a subset of these patients will not be cured...Read More
Brett S. Carver
Despite advances in the early detection and management of prostate cancer, hormone-refractory disease remains the second most common cause of male cancer deaths in the United States. Inhibition of the...Read More
Cory Abate-Shen, PhD
A Novel Human-to-Mouse-to-Human Approach for the Elucidation of Prostate Cancer Pathways and Druggable Targets—Identifying Shared Human and Mouse Molecules May Eliminate Traditional Limitations of Animal Models and Speed New Drug...Read More
Scott Williams, MD
Exploration of the Relationship between In Vivo Molecular Imaging, Cellular Response and Therapeutic Outcome in Irradiated Human Prostate Cancer A common treatment for localized prostate cancer is radiation therapy. Currently,...Read More
Matthew Smith, MD, PhD
Matthew Smith, M.D., Ph.D. is the Director of the Genitourinary Malignancies Program at the Massachusetts General Hospital Cancer Center and a Fellow at Dana-Farber Cancer Institute – Harvard Medical School....Read More
Justine Bruce
New therapeutics are urgently needed for hormone resistant prostate cancer when it emerges. Some patients with evidence of metastatic disease may receive chemotherapy while the same therapy for asymptomatic patients...Read More
Matthew Rettig, MD
A Nano-Structured Platform for Enhanced Detection of CTCs in Prostate Cancer Patients Circulating tumor cells (CTCs) are cancer cells that break away from either the primary tumor or metastatic lesions...Read More
Renata Pasqualini, PhD
Implications of Obesity in Prostate Cancer Recurrence and Progression- A Novel Fat-ablating Strategy to Overcome the Cancer Promoting Effects of Obesity Obese men are more likely to develop aggressive prostate...Read More